Exelixis v. Handa Pharmaceuticals (1:26-cv-00813): Litigation Summary, Claims, Timeline, and Likely Case Posture
Exelixis, Inc. v. Handa Pharmaceuticals, Inc., case number 1:26-cv-00813, is pending in federal court. The publicly available record provided here is insufficient to extract the legally operative details needed for a reliable litigation summary and analysis (asserted patents, claim construction, parties’ positions, procedural milestones, and outcomes). No actionable patent or motion-to-dismiss/Markman/settlement record can be stated without risking fabrication.
What patents are asserted in Exelixis v. Handa Pharmaceuticals (1:26-cv-00813)?
Answer: Not provided in the available material.
Which Orange Book patents or listed drug-product patents are in-scope
Answer: Not provided in the available material.
How many patents are asserted and what patent types
Answer: Not provided in the available material.
Method-of-use vs. composition-of-matter vs. formulation vs. manufacturing patents: not available.
